Krahn M - Search Results

1

Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.

Fowler RA, Mittmann N, Geerts W, Heels-Ansdell D, Gould MK, Guyatt G, Krahn M, Finfer S, Pinto R, Chan B, Ormanidhi O, Arabi Y, Qushmaq I, Rocha MG, Dodek P, McIntyre L, Hall R, Ferguson ND, Mehta S, Marshall JC, Doig CJ, Muscedere J, Jacka MJ, Klinger JR, Vlahakis N, Orford N, Seppelt I, Skrobik YK, Sud S, Cade JF, Cooper J, Cook D; Canadian Critical Care Trials Group; Australia and New Zealand Intensive Care Society Clinical Trials Group. Fowler RA, et al. Among authors: krahn m. JAMA. 2014 Nov 26;312(20):2135-45. doi: 10.1001/jama.2014.15101. JAMA. 2014. PMID: 25362228

2

Screening for prostate cancer. A decision analytic view.

Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Krahn MD, et al. JAMA. 1994 Sep 14;272(10):773-80. JAMA. 1994. PMID: 7521400

3

Issues in the cost-effectiveness of asthma education.

Krahn M. Krahn M. Chest. 1994 Oct;106(4 Suppl):264S-269S. doi: 10.1378/chest.106.4_supplement.264s. Chest. 1994. PMID: 7924554 Review. No abstract available.

4

The next step in guideline development: incorporating patient preferences.

Krahn M, Naglie G. Krahn M, et al. JAMA. 2008 Jul 23;300(4):436-8. doi: 10.1001/jama.300.4.436. JAMA. 2008. PMID: 18647988 No abstract available.

5

Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian Experience.

Sander B, Bauch C, Fisman DN, Fowler R, Kwong JC, McGeer A, Zivkovic Gojovic M, Krahn M. Sander B, et al. Among authors: krahn m. PLoS Curr. 2009 Dec 17;1:RRN1137. doi: 10.1371/currents.rrn1137. PLoS Curr. 2009. PMID: 20043032 Free PMC article.

6

Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005.

Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, O'Flaherty M, Krahn M, Capewell S. Wijeysundera HC, et al. Among authors: krahn m. JAMA. 2010 May 12;303(18):1841-7. doi: 10.1001/jama.2010.580. JAMA. 2010. PMID: 20460623

7

Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.

Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, Maetzel A, McGeer A, Raboud J, Scales DC, Gojovic MZ, Krahn M. Sander B, et al. Among authors: krahn m. Vaccine. 2010 Aug 31;28(38):6210-20. doi: 10.1016/j.vaccine.2010.07.010. Epub 2010 Jul 17. Vaccine. 2010. PMID: 20643091

8

Support surfaces for intraoperative prevention of pressure ulcers in patients undergoing surgery: a cost-effectiveness analysis.

Pham B, Teague L, Mahoney J, Goodman L, Paulden M, Poss J, Li J, Sikich NJ, Lourenco R, Ieraci L, Carcone S, Krahn M. Pham B, et al. Among authors: krahn m. Surgery. 2011 Jul;150(1):122-32. doi: 10.1016/j.surg.2011.03.002. Surgery. 2011. PMID: 21683861 Review.

9

Early prevention of pressure ulcers among elderly patients admitted through emergency departments: a cost-effectiveness analysis.

Pham B, Teague L, Mahoney J, Goodman L, Paulden M, Poss J, Li J, Ieraci L, Carcone S, Krahn M. Pham B, et al. Among authors: krahn m. Ann Emerg Med. 2011 Nov;58(5):468-78.e3. doi: 10.1016/j.annemergmed.2011.04.033. Epub 2011 Aug 5. Ann Emerg Med. 2011. PMID: 21820208

10

Preventing pressure ulcers in long-term care: a cost-effectiveness analysis.

Pham B, Stern A, Chen W, Sander B, John-Baptiste A, Thein HH, Gomes T, Wodchis WP, Bayoumi A, Machado M, Carcone S, Krahn M. Pham B, et al. Among authors: krahn m. Arch Intern Med. 2011 Nov 14;171(20):1839-47. doi: 10.1001/archinternmed.2011.473. Epub 2011 Sep 26. Arch Intern Med. 2011. PMID: 21949031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

570 results

Search Page